Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-20-004232
Filing Date
2020-12-15
Accepted
2020-12-15 17:09:22
Documents
4
Group Members
HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLCHARBERT DISCOVERY CO-INVESTMENT FUND I, LPHARBERT DISCOVERY FUND GP, LLCHARBERT FUND ADVISORS, INC.HARBERT MANAGEMENT CORPJACK BRYANTKENAN LUCASRAYMOND HARBERT

Document Format Files

Seq Description Document Type Size
1 ENZO BIOCHEM, INC. p20-2155sc13da.htm SC 13D/A 134889
2 EXHIBIT 99 p20-2155exh99.htm EX-99 11964
3 GRAPHIC image_003.jpg GRAPHIC 31707
4 GRAPHIC image_004.jpg GRAPHIC 11156
  Complete submission text file 0000902664-20-004232.txt   202778
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-32878 | Film No.: 201390307
SIC: 8071 Services-Medical Laboratories

Mailing Address HARBERT DISCOVERY FUND GP, LLC 2100 THIRD AVENUE NORTH, SUITE 600 BIRMINGHAM AL 35203
Business Address HARBERT DISCOVERY FUND GP, LLC 2100 THIRD AVENUE NORTH, SUITE 600 BIRMINGHAM AL 35203 205-987-5500
Harbert Discovery Fund, LP (Filed by) CIK: 0001626127 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A